Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Full year organic growth is fueled by prosthetic urology ... Boston Scientific. We obviously gave 2025 guide. But as we've said before at another conference in January, we're investing for ...

So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DOJoPAWP.js ...

Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

and urology, among other fields. The company a has diverse portfolio of products and technologies and provides it to healthcare professionals and patients worldwide. Boston Scientific Corporation ...

We live in an era when many sectors are dynamic, and one of the many that’s quite active in the past several years is the ...

We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to ...

In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...